HOME Top Market Reports Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018

Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018

By: marketsandmarkets.com
Publishing Date: April 2014
Report Code: MD 2349

 

Enquiry Before Buying
 
purchase report
download pdf  request for customisation


Tissue diagnostics are an important set of techniques, primarily used for the diagnosis, monitoring and management of cancer. The market includes instruments, reagents and kits used to determine the stage, prognosis, and treatment course of the disease. Increasing global incidences of cancer, the adoption of tissue diagnostic products as companion diagnostics in personalized medicine for cancer and the rapidly aging global population are expected to be the three most important growth drivers for the global market.

The report segments this market by technology, disease, product, end user and geography. The IHC technology segment commanded the largest share of the global market and is also poised to grow at the highest CAGR between 2013 and 2018, due to the increasing use of IHC products as companion diagnostics in personalized medicine for cancer.

Due to its rapidly increasing incidence, the breast cancer disease segment commanded the largest share of the global market. Breast cancer is the most common form of cancer in women and is highly amenable for tissue diagnostics. It is also poised to grow at the highest CAGR between 2013 and 2018.

Tissue diagnostics finds primary application for diagnosis of cancer. As such, the hospital end-user segment commanded the largest share of the global market, while the research laboratories end-user segment is poised to grow at the highest CAGR between 2013 and 2018. The use of tissue diagnostic products for research purposes is expected to remain low.

The Americas accounted for the largest share of the global market. The Patient Protection and Affordable Care Act (PPACA) introduced in the U.S. in March 2010 is expected to expand insurance access to more than 30 million U.S. citizens. This is expected to drive the demand for advanced cancer diagnostics, including tissue diagnostics, in this important geographic segment. On the other hand, the BRIC and RoW geographic segments are expected to grow rapidly at a higher CAGR in the forecast period between 2013 and 2018, owing to the large and rapidly aging population, and large untapped potential of these markets.

The major players in the tissue diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.). Other important players in this market are Biogenex Laboratories (U.S.), Sigma-Aldrich (U.S.), Cell Signaling Technology (U.S.), Bio SB (U.S.) and Life Technologies (U.S.).

Scope of the Report:

This research report categorizes the global tissue diagnostics market into the following segments:

By Technology

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital pathology & Workflow
  • Special Staining

By Disease

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-small-cell Lung Cancer
  • Others

By End Users

  • Hospitals
  • Pharmaceutical Companies
  • Research Laboratories
  • Contract Research Organizations
  • Others

By Region

  • The Americas
  • Europe
  • BRIC
  • Japan
  • RoW

Table Of Contents
 
1 Introduction (Page No. - 18)
    1.1 Objectives Of The Study
    1.2 Report Description
    1.3 Markets Covered
    1.4 Stakeholders
    1.5 Research Methodology
          1.5.1 Secondary Research
          1.5.2 Primary Research
                  1.5.2.1 Key Data Points From Primary Sources
          1.5.3 Market Size Estimation Methodology
          1.5.4 Market Forecast
          1.5.5 Market Data Validation & Data Triangulation
    1.6 Assumptions

2 Executive Summary (Page No. - 30)

3 Premium Insights (Page No. - 34)

4 Market Overview (Page No. - 41)
    4.1 Introduction
    4.2 Market Segmentation
    4.3 Market Dynamics
          4.3.1 Drivers
                  4.3.1.1 Rising Incidence Of Cancer Is The Primary Driver For The Tissue Diagnostics Market
                  4.3.1.2 Rapidly Aging Population Will Increase The Disease Burden Of Non-Communicable Diseases
                  4.3.1.3 Increased Use Of Personalized Medicine For Cancer Will Drive The Demand For Tissue-Based Companion Diagnostic Tests
                  4.3.1.4 Growth in The Ivd Market Will Aid The Growth Of The Tissue Diagnostics Market
          4.3.2 Restraints
                  4.3.2.1 Lack Of Budget To Restrict The Growth Of The Market
                  4.3.2.2 Stringent Regulatory Framework Acts As A Major Challenge For The Tissue Diagnostics Market
    4.4 Market Share Analysis
    4.5 Porter’s Analysis
          4.5.1 Threat From New Entrants
          4.5.2 Threat From Substitutes
          4.5.3 Bargaining Power Of Buyers
          4.5.4 Bargaining Power Of Suppliers
          4.5.5 Competitive Rivalry Among Existing Players

5 Global Tissue Diagnostics Market, By Technology (Page No. - 55)
    5.1 Introduction
    5.2 Immunohistochemistry (IHC)
    5.3 In Situ Hybridization (ISH)
    5.4 Digital Pathology and Workflow Management
    5.5 Special Staining

6 Global Tissue Diagnostics Market, By Disease (Page No. - 68)
    6.1 Introduction
    6.2 Breast Cancer
    6.3 Gastric Cancer
    6.4 Lymphoma
    6.5 Prostate Cancer
    6.6 Non-Small Cell Lung Carcinoma (NSCLC)
    6.7 Other Diseases

7 Global Tissue Diagnotics Market, By Product (Page No. - 85)
    7.1 Introduction
    7.2 Instruments
    7.3 Consumables

8 Global Tissue Diagnostics Market, By End User (Page No. - 93)
    8.1 Introduction
    8.2 Hospitals
    8.3 Pharmaceutical Companies
    8.4 Research Laboratories
    8.5 Contract Research Organizations (CRO)
    8.6 Other End-Users

9 Geographic Analysis (Page No. - 105)
    9.1 Introduction
    9.2 The Americas
          9.2.1 U.S.
          9.2.2 Canada
          9.2.3 Mexico
          9.2.4 Chile
          9.2.5 Rest Of Americas (ROA)
    9.3 Europe
          9.3.1 Germany
          9.3.2 France
          9.3.3 Italy
          9.3.4 Spain
          9.3.5 U.K.
          9.3.6 Rest Of Europe (ROE)
    9.4 BRIC
          9.4.1 Brazil
          9.4.2 China
          9.4.3 India
          9.4.4 Russia
    9.5 Japan
    9.6 Rest Of The World (ROW)

10 Competitive Landscape (Page No. - 195)
    10.1 Introduction
    10.2 New Product Launches
    10.3 Agreements, Collaborations, Expansions, Joint Ventures and Partnerships
    10.4 Mergers and Acquisitions
    10.5 Other Developments

11 Company Profiles (Business Overview, Products & Services, Key Strategy, & Recent Developments)* (Page No. - 204)
    11.1 Abbott Laboratories, Inc.
    11.2 Agilent Technologies
    11.3 Biogenex Laboratories
    11.4 Bio Sb.
    11.5 Cell Signalling Technology, Inc.
    11.6 Danaher Corporation.
    11.7 Life Technologies
    11.8 Roche
    11.9 Sigma Aldrich
    11.1 Thermo Fisher Scientific

*Details on Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case Of Unlisted Companies.

Appendix  (Page No. - 251)


List Of Tables (97 Tables)

Table 1 Global Tissue Diagnostics Market, By Technology, 2011–2018 ($Million)
Table 2 Global IHC Market, By Geography, 2011–2018 ($Million)
Table 3 Global ISH Market, By Geography, 2011–2018 ($Million)
Table 4 Global Digital Pathology and Workflow Management Market, By Geography, 2011–2018 ($Million)
Table 5 Global Special Staining Market, By Geography, 2011–2018 ($Million)
Table 6 Global Market, By Disease, 2011–2018 ($Million)
Table 7 Global Breast Cancer Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 8 Global Gastric Cancer Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 9 Global Lymphoma Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 10 Global Prostate Cancer Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 11 Global NSCLC Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 12 Global Other Diseases Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 13 Global Market, By Product, 2011–2018 ($Million)
Table 14 Global Tissue Diagnostics Instruments Market, By Geography, 2011–2018 ($Million)
Table 15 Global Tissue Diagnostics Consumables Market, By Geography, 2011–2018 ($Million)
Table 16 Global Tissue Diagnostics Market, By End User, 2011–2018 ($Million)
Table 17 Global Hospitals Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 18 Global Pharmaceutical Companies Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 19 Global Academic Research Laboratories Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 20 Global CRO Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 21 Global Other End-Users Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 22 Global Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 23 The Americas: Market, By Geography, 2011–2018 ($Million)
Table 24 U.S.: Market, By Technology, 2011–2018 ($Million)
Table 25 U.S.: Market, By Disease, 2011–2018 ($Million)
Table 26 U.S.: Market, By Product, 2011–2018 ($Million)
Table 27 U.S.: Market, By End User, 2011–2018 ($Million)
Table 28 Canada: Market, By Technology, 2011–2018 ($Million)
Table 29 Canada: Market, By Disease, 2011–2018 ($Million)
Table 30 Canada: Market, By Product, 2011–2018 ($Million)
Table 31 Canada: Market, By End User, 2011–2018 ($Million)
Table 32 Mexico: Market, By Technology, 2011–2018 ($Million)
Table 33 Mexico: Market, By Disease, 2011–2018 ($Million)
Table 34 Mexico: Market, By Product, 2011–2018 ($Million)
Table 35 Mexico: Market, By End User, 2011–2018 ($Million)
Table 36 Chile: Market, By Technology, 2011–2018 ($Million)
Table 37 Chile: Market, By Disease, 2011–2018 ($Million)
Table 38 Chile: Market, By Product, 2011–2018 ($Million)
Table 39 Chile: Market, By End User, 2011–2018 ($Million)
Table 40 ROA: Market, By Technology, 2011–2018 ($Million)
Table 41 ROA: Market, By Disease, 2011–2018 ($Million)
Table 42 ROA: Market, By Product, 2011–2018 ($Million)
Table 43 ROA: Market, By End User, 2011–2018 ($Million)
Table 44 Europe: Market, By Geography, 2011–2018 ($Million)
Table 45 Germany: Market, By Technology, 2011–2018 ($Million)
Table 46 Germany: Market, By Disease, 2011–2018 ($Million)
Table 47 Germany: Market, By Product, 2011–2018 ($Million)
Table 48 Germany: Market, By End User, 2011–2018 ($Million)
Table 49 France: Market, By Technology, 2011–2018 ($Million)
Table 50 France: Market, By Disease, 2011–2018 ($Million)
Table 51 France: Market, By Product, 2011–2018 ($Million)
Table 52 France: Market, By End User, 2011–2018 ($Million)
Table 53 Italy: Market, By Technology, 2011–2018 ($Million)
Table 54 Italy: Market, By Disease, 2011–2018 ($Million)
Table 55 Italy: Market, By Product, 2011–2018 ($Million)
Table 56 Italy: Market, By End User, 2011–2018 ($Million)
Table 57 Spain: Market, By Technology, 2011–2018 ($Million)
Table 58 Spain: Market, By Disease, 2011–2018 ($Million)
Table 59 Spain: Market, By Product, 2011–2018 ($Million)
Table 60 Spain: Market, By End User, 2011–2018 ($Million)
Table 61 U.K.: Market, By Technology, 2011–2018 ($Million)
Table 62 U.K.: Market, By Disease, 2011–2018 ($Million)
Table 63 U.K.: Market, By Product, 2011–2018 ($Million)
Table 64 U.K.: Market, By End User, 2011–2018 ($Million)
Table 65 ROE: Market, By Technology, 2011–2018 ($Million)
Table 66 ROE: Market, By Disease, 2011–2018 ($Million)
Table 67 ROE: Market, By Product, 2011–2018 ($Million)
Table 68 ROE: Market, By End User, 2011–2018 ($Million)
Table 69 BRIC: Market, By Geography, 2011–2018 ($Million)
Table 70 Brazil: Market, By Technology, 2011–2018 ($Million)
Table 71 Brazil: Market, By Disease, 2011–2018 ($Million)
Table 72 Brazil: Market, By Product, 2011–2018 ($Million)
Table 73 Brazil: Market, By End User, 2011–2018 ($Million)
Table 74 China: Market, By Technology, 2011–2018 ($Million)
Table 75 China: Market, By Disease, 2011–2018 ($Million)
Table 76 China: Market, By Product, 2011–2018 ($Million)
Table 77 China: Market, By End User, 2011–2018 ($Million)
Table 78 India: Market, By Technology, 2011–2018 ($Million)
Table 79 India: Market, By Disease, 2011–2018 ($Million)
Table 80 India: Market, By Product, 2011–2018 ($Million)
Table 81 India: Market, By End User, 2011–2018 ($Million)
Table 82 Russia: Market, By Technology, 2011–2018 ($Million)
Table 83 Russia: Market, By Disease, 2011–2018 ($Million)
Table 84 Russia: Market, By Product, 2011–2018 ($Million)
Table 85 Russia: Market, By End User, 2011–2018 ($Million)
Table 86 Japan: Market, By Technology, 2011–2018 ($Million)
Table 87 Japan: Market, By Disease, 2011–2018 ($Million)
Table 88 Japan: Market, By Product, 2011–2018 ($Million)
Table 89 Japan: Market, By End User, 2011–2018 ($Million)
Table 90 ROW: Market, By Technology, 2011–2018 ($Million)
Table 91 ROW: Market, By Disease, 2011–2018 ($Million)
Table 92 ROW: Market, By Product, 2011–2018 ($Million)
Table 93 ROW: Market, By End User, 2011–2018 ($Million)
Table 94 New Product Launch, 2010–2014
Table 95 Agreements, Partnerships, Collaborations & Joint Ventures, 2010–2014
Table 96 Mergers and Acquisitions, 2010–2014
Table 97 Other Developments, 2010–2014
 
 
List Of Figures (37 Figures)

Figure 1 Research Methodology
Figure 2 Market Size Estimation Methodology
Figure 3 Market Forecasting Model
Figure 4 Data Triangulation Methodology
Figure 5 Global Tissue Diagnostics Market By Technology, 2013 Vs. 2018 ($Million)
Figure 6 Global Market,  By Disease, 2013 Vs. 2018 ($Million)
Figure 7 Global Market, By End User, 2013 Vs. 2018 ($Million)
Figure 8 Global Market, By Geography, 2013 Vs. 2018 ($Million)
Figure 9 Global Market, Geographic Analysis, 2013 ($Million)
Figure 10 Global Market, By Disease, 2013
Figure 11 Global Market, By Disease, 2013 Vs. 2018
Figure 12 Global Market, By Disease, 2011–2018 (Market Sizes & Growth Rates)
Figure 13 Global Market, By Technology, 2013
Figure 14 Global Market, By Technology, 2013 Vs. 2018
Figure 15 Global Market, By Technology, 2011–2018 (Market Sizes & Growth Rates)
Figure 16 Global Market, By End User, 2013
Figure 17 Global Market, By End User, 2013 Vs. 2018
Figure 18 Global Market, By End User, 2011–2018 (Market Sizes & Growth Rates)
Figure 19 Market Segmentation
Figure 20 Market—Drivers & Restraints
Figure 21 Market Share Analysis, By Key Player, 2013
Figure 22 Porter’s Five Forces Analysis
Figure 23 Global Market Segmentation, By Technology
Figure 24 Global Market, By Technology, 2013–2018
Figure 25 Global Market Segmentation, By Disease
Figure 26 Global Market, By Disease, 2013–2018
Figure 27 Global Market Segmentation, By End Users
Figure 28 Global Market, By End User, 2013–2018
Figure 29 Global Market, By Region, 2013
Figure 30 Key Growth Strategies, Tissue Diagnostics Market, 2010-2014
Figure 31 Abbott Laboratories, Inc. Overview
Figure 32 Agilent Technologies Overview
Figure 33 Danaher Corporation. Overview
Figure 34 Life Technologies Overview
Figure 35 Roche Overview
Figure 36 Sigma Aldrich Overview
Figure 37 Thermo Fisher Scientific Overview

The global tissue diagnostics market is expected to grow at a CAGR of close to 6.97% between 2013 and 2018, to reach $3,924.01 million in 2018. Tissue diagnostics is used to determine the stage, prognosis, and treatment course of cancer. The rapidly increasing incidence of cancer and the increasing use of tissue diagnostic products for companion diagnostics in personalized medicine will be the two most important growth drivers for this market during the forecast period between 2013 and 2018. Furthermore, as advanced age is considered to be an important risk factor for cancer, the rapidly aging global population will further drive the demand for tissue diagnostic products.

The report provides a granular understanding of the market. It segments the global tissue diagnostics market by technology, disease, product, end user, and geography. Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the market included in this report. The IHC technology segment commanded the largest share of the global market and is also poised to grow at the highest CAGR between 2013 and 2018, owing to its increasing use as companion diagnostics in personalized medicine for cancer.

The disease segments included in this report are breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other diseases segments. The breast cancer disease segment commanded the largest share of the global market, and is also poised to grow at the highest CAGR between 2013 and 2018, due to the sharp increase in the incidences of disease owing to lifestyle changes and environmental factors.

The end-user segments of the tissue diagnostics market included in this report are hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users like reference laboratories. The hospital end-user segment commanded the largest share of the global market, while the research laboratories end-user segment is poised to grow at the highest CAGR between 2013 and 2018.

The geographic segments of the global tissue diagnostics market are the Americas, Europe, BRIC, Japan, and the Rest of the World (RoW). The Americas is further divided into the U.S., Canada, Mexico, Chile, and the Rest of the Americas. The Europe segment is further divided into the regional segments of Germany, France, Italy, Spain, the U.K., and the Rest of Europe. The BRIC segment includes Brazil, Russia, India, and China.

The report maps the technology, disease, product, and end-user profiles in each of the above-mentioned regional and geographic segments. It provides a granular understanding of the current market size and provides a market forecast for 2018.

Global Tissue Diagnostics Market, Market Snapshot, 2018 ($Million)


Tissue Diagnostics Market

Source: Annual Reports, SEC Filings, Expert Interviews, and MarketsandMarkets Analysis

The major players in the market are Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Bio SB (U.S.), Cell Signaling Technology (U.S.), Danaher Corporation (U.S.), Roche Diagnostics (Switzerland), Sigma-Aldrich (U.S.), and Thermo Fisher Scientific (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports